| 1 |
Impact of drug use policy on the appropriate use of direct acting antiviral agents for Hepatitis C in Saudi Arabia |
|
| | AhmedSaqer Alotaibi, Nour Shamas, UmairUddin Ansari, FaisalM Sanai, Ali Alshahrani, AhmedIbrahim Fathelrahman, MohammedAli Aseeri | | | Journal of Pharmacy And Bioallied Sciences. 2021; 13(3): 317 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Evaluation of outcomes of 8-week therapy with ledipasvir/sofosbuvir or glecaprevir/pibrentasvir in veterans with hepatitis C infection |
|
| | LA Lemoine, M* Segarra-Newnham | | | Annals of Clinical Gastroenterology and Hepatology. 2019; 3(1): 027 | | | [Pubmed] [Google Scholar] [DOI] | |
|
